Clinical Trials Directory

Trials / Completed

CompletedNCT03001154

Virtual Reality Exposure Therapy for Speech Anxiety Using Commercial Hardware and Software

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Stockholm University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Virtual Reality Exposure Therapy (VRET) is an efficacious treatment of fear and anxiety, but because of the high financial costs and technical complexity of the past generation of VR hardware, there has been no large-scale implementation of this promising treatment. The present study will investigate whether off-the-shelf, commercial VR hardware and software can be used as stimuli material to conduct in-session exposure therapy for speech anxiety. The study will recruit n=25+25 participants from the general public suffering from substantial speech anxiety, who will be randomized to either a waiting-list, or one-session VRET with a therapist, followed by four weeks of a progressive maintenance program encouraging in-vivo exposure. The waiting-list group will then receive an Internet-delivered VRET treatment program.

Conditions

Interventions

TypeNameDescription
BEHAVIORALFace-to-face Virtual Reality Exposure TherapyIn session, systematic, hierarchical exposure to feared stimuli with therapist.
BEHAVIORALInternet-administered Virtual Reality Exposure TherapyTherapist-guided, Internet-administered Virtual Reality Exposure Therapy self-help program
OTHERWaiting-listWeekly assessments of public speaking

Timeline

Start date
2017-01-01
Primary completion
2017-05-01
Completion
2018-06-01
First posted
2016-12-22
Last updated
2019-03-07

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT03001154. Inclusion in this directory is not an endorsement.